Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: The AMISTAD-2 trial

Robert A. Kloner, Mervyn B. Forman, Raymond J. Gibbons, Allan M. Ross, R. Wayne Alexander, Gregg W. Stone

Research output: Contribution to journalArticlepeer-review

196 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: The AMISTAD-2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences